Skip to content

Dr. Akshay A Reshmi

Qualification: MBBS, DNB, MD Radiodiagnosis

Consultant - Fetal Medicine

DEPARTMENTFetal Medicine, Fetal Medicine & Radiology, Radiology

EXPERIENCE
5+ Years

UNITJeevanbhimanagar, Bangalore

LANGUAGEEnglish, Kannada, Hindi

Working Time05:00 am to 08:00pm Monday to Saturday

Overview

Dr. Akshay A Reshmi is an experienced Radiologist and Fetal Medicine Specialist with over 5 + years of expertise in diagnostic imaging and prenatal evaluation. Dr. Akshay A Reshmi has Skills in NT scan, anomaly scan, fetal echocardiography, growth scans & dopplers according to FMF UK and ISUOG guidelines, Non-obstetric Ultrasound studies and dopplers, Experience with multiple order pregnancies, high risk pregnancies and IVF pregnancies, CT and MRI analysis with appropriate protocol selection, Radiographic investigations , Analytical and Critical Thinking, Radiation Exposure Minimization, Eliciting detailed medical history to augment radiological investigations, Fetal interventions, Genetic counselling.

Academic achievements: 

Won first prize in Oral scientific paper presentation in National conferenceGlobal radiology Conclave- IRIA on Comparison of Biparametric MRI and Multiparametric MRI with histopathology in diagnosis of prostate cancer ∙ Educational exhibit “Bilateral basal ganglia buzz : A pictorial essay” at European congress of Radiology (ECR) at Vienna, Feb 2024 ∙ Scientific exhibit “Opportunistic osteoporosis screening via abdominal CT/lumbar spine MRI: a snap check” at European congress of Radiology (ECR) at Vienna, Feb 2024 ∙ Presented case report on ‘Endovascular approach to the vein of Galen malformation’ in National conference of Indian Society of Paediatric Radiology (ISPR), Delhi. ∙ Presented case report on ‘Unusual case of paratesticular tumor’ in Karnataka state conference IRIA, Mangalore. ∙ Cleared FRCR 2A and awaiting for final partresults. ∙ Secured FAGE degree from Manipal University. ∙ Organizing committee member of CME on Cardiac CT at Father Mullers medical college – 2022.